nodes	percent_of_prediction	percent_of_DWPC	metapath
Degarelix—Arrhythmia—Prednisolone—ankylosing spondylitis	0.00334	0.00334	CcSEcCtD
Degarelix—Erythema—Prednisolone—ankylosing spondylitis	0.00325	0.00325	CcSEcCtD
Degarelix—Eye disorder—Methylprednisolone—ankylosing spondylitis	0.0032	0.0032	CcSEcCtD
Degarelix—Cardiac disorder—Methylprednisolone—ankylosing spondylitis	0.00318	0.00318	CcSEcCtD
Degarelix—Erectile dysfunction—Prednisone—ankylosing spondylitis	0.00313	0.00313	CcSEcCtD
Degarelix—Angiopathy—Methylprednisolone—ankylosing spondylitis	0.00311	0.00311	CcSEcCtD
Degarelix—Immune system disorder—Methylprednisolone—ankylosing spondylitis	0.0031	0.0031	CcSEcCtD
Degarelix—Mediastinal disorder—Methylprednisolone—ankylosing spondylitis	0.00309	0.00309	CcSEcCtD
Degarelix—Weight increased—Prednisone—ankylosing spondylitis	0.00309	0.00309	CcSEcCtD
Degarelix—Arrhythmia—Triamcinolone—ankylosing spondylitis	0.00307	0.00307	CcSEcCtD
Degarelix—Weight decreased—Prednisone—ankylosing spondylitis	0.00307	0.00307	CcSEcCtD
Degarelix—Vision blurred—Prednisolone—ankylosing spondylitis	0.00307	0.00307	CcSEcCtD
Degarelix—Arrhythmia—Methylprednisolone—ankylosing spondylitis	0.00306	0.00306	CcSEcCtD
Degarelix—Hyperglycaemia—Prednisone—ankylosing spondylitis	0.00306	0.00306	CcSEcCtD
Degarelix—Ill-defined disorder—Prednisolone—ankylosing spondylitis	0.00302	0.00302	CcSEcCtD
Degarelix—Depression—Prednisone—ankylosing spondylitis	0.00302	0.00302	CcSEcCtD
Degarelix—Mental disorder—Methylprednisolone—ankylosing spondylitis	0.003	0.003	CcSEcCtD
Degarelix—Erythema—Triamcinolone—ankylosing spondylitis	0.00299	0.00299	CcSEcCtD
Degarelix—Erythema—Methylprednisolone—ankylosing spondylitis	0.00299	0.00299	CcSEcCtD
Degarelix—Malnutrition—Methylprednisolone—ankylosing spondylitis	0.00299	0.00299	CcSEcCtD
Degarelix—Acute coronary syndrome—Prednisone—ankylosing spondylitis	0.00298	0.00298	CcSEcCtD
Degarelix—Myocardial infarction—Prednisone—ankylosing spondylitis	0.00297	0.00297	CcSEcCtD
Degarelix—Breast disorder—Methotrexate—ankylosing spondylitis	0.00296	0.00296	CcSEcCtD
Degarelix—Malaise—Prednisolone—ankylosing spondylitis	0.00293	0.00293	CcSEcCtD
Degarelix—Eye disorder—Betamethasone—ankylosing spondylitis	0.00291	0.00291	CcSEcCtD
Degarelix—Eye disorder—Dexamethasone—ankylosing spondylitis	0.00291	0.00291	CcSEcCtD
Degarelix—Back pain—Triamcinolone—ankylosing spondylitis	0.00289	0.00289	CcSEcCtD
Degarelix—Angiopathy—Dexamethasone—ankylosing spondylitis	0.00283	0.00283	CcSEcCtD
Degarelix—Angiopathy—Betamethasone—ankylosing spondylitis	0.00283	0.00283	CcSEcCtD
Degarelix—Hypertension—Prednisolone—ankylosing spondylitis	0.00281	0.00281	CcSEcCtD
Degarelix—Arrhythmia—Dexamethasone—ankylosing spondylitis	0.00279	0.00279	CcSEcCtD
Degarelix—Arrhythmia—Betamethasone—ankylosing spondylitis	0.00279	0.00279	CcSEcCtD
Degarelix—Ill-defined disorder—Triamcinolone—ankylosing spondylitis	0.00278	0.00278	CcSEcCtD
Degarelix—Ill-defined disorder—Methylprednisolone—ankylosing spondylitis	0.00277	0.00277	CcSEcCtD
Degarelix—Alopecia—Dexamethasone—ankylosing spondylitis	0.00276	0.00276	CcSEcCtD
Degarelix—Alopecia—Betamethasone—ankylosing spondylitis	0.00276	0.00276	CcSEcCtD
Degarelix—Discomfort—Prednisolone—ankylosing spondylitis	0.00274	0.00274	CcSEcCtD
Degarelix—Abdominal discomfort—Methotrexate—ankylosing spondylitis	0.00272	0.00272	CcSEcCtD
Degarelix—Erythema—Dexamethasone—ankylosing spondylitis	0.00271	0.00271	CcSEcCtD
Degarelix—Erythema—Betamethasone—ankylosing spondylitis	0.00271	0.00271	CcSEcCtD
Degarelix—Malaise—Triamcinolone—ankylosing spondylitis	0.0027	0.0027	CcSEcCtD
Degarelix—Malaise—Methylprednisolone—ankylosing spondylitis	0.00269	0.00269	CcSEcCtD
Degarelix—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.00266	0.00266	CcSEcCtD
Degarelix—Dysuria—Methotrexate—ankylosing spondylitis	0.00265	0.00265	CcSEcCtD
Degarelix—Erectile dysfunction—Methotrexate—ankylosing spondylitis	0.00261	0.00261	CcSEcCtD
Degarelix—Hypertension—Triamcinolone—ankylosing spondylitis	0.00258	0.00258	CcSEcCtD
Degarelix—Hypertension—Methylprednisolone—ankylosing spondylitis	0.00258	0.00258	CcSEcCtD
Degarelix—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.00257	0.00257	CcSEcCtD
Degarelix—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.00254	0.00254	CcSEcCtD
Degarelix—Eye disorder—Prednisone—ankylosing spondylitis	0.00254	0.00254	CcSEcCtD
Degarelix—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.00252	0.00252	CcSEcCtD
Degarelix—Depression—Methotrexate—ankylosing spondylitis	0.00252	0.00252	CcSEcCtD
Degarelix—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.00252	0.00252	CcSEcCtD
Degarelix—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.00252	0.00252	CcSEcCtD
Degarelix—Discomfort—Triamcinolone—ankylosing spondylitis	0.00252	0.00252	CcSEcCtD
Degarelix—Discomfort—Methylprednisolone—ankylosing spondylitis	0.00251	0.00251	CcSEcCtD
Degarelix—Dry mouth—Triamcinolone—ankylosing spondylitis	0.00249	0.00249	CcSEcCtD
Degarelix—Renal failure—Methotrexate—ankylosing spondylitis	0.00249	0.00249	CcSEcCtD
Degarelix—Angiopathy—Prednisone—ankylosing spondylitis	0.00246	0.00246	CcSEcCtD
Degarelix—Immune system disorder—Prednisone—ankylosing spondylitis	0.00245	0.00245	CcSEcCtD
Degarelix—Malaise—Dexamethasone—ankylosing spondylitis	0.00245	0.00245	CcSEcCtD
Degarelix—Malaise—Betamethasone—ankylosing spondylitis	0.00245	0.00245	CcSEcCtD
Degarelix—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.00244	0.00244	CcSEcCtD
Degarelix—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.00244	0.00244	CcSEcCtD
Degarelix—Arrhythmia—Prednisone—ankylosing spondylitis	0.00243	0.00243	CcSEcCtD
Degarelix—Insomnia—Prednisolone—ankylosing spondylitis	0.0024	0.0024	CcSEcCtD
Degarelix—Alopecia—Prednisone—ankylosing spondylitis	0.0024	0.0024	CcSEcCtD
Degarelix—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.00239	0.00239	CcSEcCtD
Degarelix—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.00239	0.00239	CcSEcCtD
Degarelix—Mental disorder—Prednisone—ankylosing spondylitis	0.00238	0.00238	CcSEcCtD
Degarelix—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.00237	0.00237	CcSEcCtD
Degarelix—Erythema—Prednisone—ankylosing spondylitis	0.00236	0.00236	CcSEcCtD
Degarelix—Malnutrition—Prednisone—ankylosing spondylitis	0.00236	0.00236	CcSEcCtD
Degarelix—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.00236	0.00236	CcSEcCtD
Degarelix—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.00236	0.00236	CcSEcCtD
Degarelix—Hypertension—Betamethasone—ankylosing spondylitis	0.00234	0.00234	CcSEcCtD
Degarelix—Hypertension—Dexamethasone—ankylosing spondylitis	0.00234	0.00234	CcSEcCtD
Degarelix—Discomfort—Dexamethasone—ankylosing spondylitis	0.00228	0.00228	CcSEcCtD
Degarelix—Discomfort—Betamethasone—ankylosing spondylitis	0.00228	0.00228	CcSEcCtD
Degarelix—Hypotension—Methylprednisolone—ankylosing spondylitis	0.00228	0.00228	CcSEcCtD
Degarelix—Pain—Prednisolone—ankylosing spondylitis	0.00227	0.00227	CcSEcCtD
Degarelix—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.00224	0.00224	CcSEcCtD
Degarelix—Vision blurred—Prednisone—ankylosing spondylitis	0.00223	0.00223	CcSEcCtD
Degarelix—Urethral disorder—Methotrexate—ankylosing spondylitis	0.00222	0.00222	CcSEcCtD
Degarelix—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.00222	0.00222	CcSEcCtD
Degarelix—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.00222	0.00222	CcSEcCtD
Degarelix—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.00222	0.00222	CcSEcCtD
Degarelix—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.00222	0.00222	CcSEcCtD
Degarelix—Insomnia—Triamcinolone—ankylosing spondylitis	0.00221	0.00221	CcSEcCtD
Degarelix—Insomnia—Methylprednisolone—ankylosing spondylitis	0.0022	0.0022	CcSEcCtD
Degarelix—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.00219	0.00219	CcSEcCtD
Degarelix—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.00219	0.00219	CcSEcCtD
Degarelix—Anaemia—Prednisone—ankylosing spondylitis	0.00219	0.00219	CcSEcCtD
Degarelix—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.00218	0.00218	CcSEcCtD
Degarelix—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.00217	0.00217	CcSEcCtD
Degarelix—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.00217	0.00217	CcSEcCtD
Degarelix—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.00214	0.00214	CcSEcCtD
Degarelix—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.00214	0.00214	CcSEcCtD
Degarelix—Malaise—Prednisone—ankylosing spondylitis	0.00213	0.00213	CcSEcCtD
Degarelix—Eye disorder—Methotrexate—ankylosing spondylitis	0.00212	0.00212	CcSEcCtD
Degarelix—Urticaria—Prednisolone—ankylosing spondylitis	0.00211	0.00211	CcSEcCtD
Degarelix—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.00211	0.00211	CcSEcCtD
Degarelix—Fatigue—Triamcinolone—ankylosing spondylitis	0.00211	0.00211	CcSEcCtD
Degarelix—Fatigue—Methylprednisolone—ankylosing spondylitis	0.0021	0.0021	CcSEcCtD
Degarelix—Pain—Triamcinolone—ankylosing spondylitis	0.00209	0.00209	CcSEcCtD
Degarelix—Hypotension—Betamethasone—ankylosing spondylitis	0.00207	0.00207	CcSEcCtD
Degarelix—Hypotension—Dexamethasone—ankylosing spondylitis	0.00207	0.00207	CcSEcCtD
Degarelix—Angiopathy—Methotrexate—ankylosing spondylitis	0.00206	0.00206	CcSEcCtD
Degarelix—Immune system disorder—Methotrexate—ankylosing spondylitis	0.00205	0.00205	CcSEcCtD
Degarelix—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.00205	0.00205	CcSEcCtD
Degarelix—Hypertension—Prednisone—ankylosing spondylitis	0.00204	0.00204	CcSEcCtD
Degarelix—Chills—Methotrexate—ankylosing spondylitis	0.00204	0.00204	CcSEcCtD
Degarelix—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.00202	0.00202	CcSEcCtD
Degarelix—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.00202	0.00202	CcSEcCtD
Degarelix—Arthralgia—Prednisone—ankylosing spondylitis	0.00201	0.00201	CcSEcCtD
Degarelix—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.00201	0.00201	CcSEcCtD
Degarelix—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.00201	0.00201	CcSEcCtD
Degarelix—Alopecia—Methotrexate—ankylosing spondylitis	0.00201	0.00201	CcSEcCtD
Degarelix—Insomnia—Betamethasone—ankylosing spondylitis	0.002	0.002	CcSEcCtD
Degarelix—Insomnia—Dexamethasone—ankylosing spondylitis	0.002	0.002	CcSEcCtD
Degarelix—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.002	0.002	CcSEcCtD
Degarelix—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.00199	0.00199	CcSEcCtD
Degarelix—Discomfort—Prednisone—ankylosing spondylitis	0.00199	0.00199	CcSEcCtD
Degarelix—Mental disorder—Methotrexate—ankylosing spondylitis	0.00199	0.00199	CcSEcCtD
Degarelix—Erythema—Methotrexate—ankylosing spondylitis	0.00198	0.00198	CcSEcCtD
Degarelix—Malnutrition—Methotrexate—ankylosing spondylitis	0.00198	0.00198	CcSEcCtD
Degarelix—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.00196	0.00196	CcSEcCtD
Degarelix—Urticaria—Triamcinolone—ankylosing spondylitis	0.00194	0.00194	CcSEcCtD
Degarelix—Urticaria—Methylprednisolone—ankylosing spondylitis	0.00194	0.00194	CcSEcCtD
Degarelix—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.00193	0.00193	CcSEcCtD
Degarelix—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.00193	0.00193	CcSEcCtD
Degarelix—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.00193	0.00193	CcSEcCtD
Degarelix—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.00193	0.00193	CcSEcCtD
Degarelix—Decreased appetite—Betamethasone—ankylosing spondylitis	0.00193	0.00193	CcSEcCtD
Degarelix—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.00191	0.00191	CcSEcCtD
Degarelix—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.00191	0.00191	CcSEcCtD
Degarelix—Back pain—Methotrexate—ankylosing spondylitis	0.00191	0.00191	CcSEcCtD
Degarelix—Fatigue—Betamethasone—ankylosing spondylitis	0.00191	0.00191	CcSEcCtD
Degarelix—Fatigue—Dexamethasone—ankylosing spondylitis	0.00191	0.00191	CcSEcCtD
Degarelix—Pain—Dexamethasone—ankylosing spondylitis	0.00189	0.00189	CcSEcCtD
Degarelix—Pain—Betamethasone—ankylosing spondylitis	0.00189	0.00189	CcSEcCtD
Degarelix—Nervous system disorder—Prednisone—ankylosing spondylitis	0.00189	0.00189	CcSEcCtD
Degarelix—Skin disorder—Prednisone—ankylosing spondylitis	0.00187	0.00187	CcSEcCtD
Degarelix—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.00187	0.00187	CcSEcCtD
Degarelix—Vision blurred—Methotrexate—ankylosing spondylitis	0.00186	0.00186	CcSEcCtD
Degarelix—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.00183	0.00183	CcSEcCtD
Degarelix—Anaemia—Methotrexate—ankylosing spondylitis	0.00183	0.00183	CcSEcCtD
Degarelix—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.00183	0.00183	CcSEcCtD
Degarelix—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.00183	0.00183	CcSEcCtD
Degarelix—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.00181	0.00181	CcSEcCtD
Degarelix—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.00181	0.00181	CcSEcCtD
Degarelix—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.0018	0.0018	CcSEcCtD
Degarelix—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.0018	0.0018	CcSEcCtD
Degarelix—Malaise—Methotrexate—ankylosing spondylitis	0.00178	0.00178	CcSEcCtD
Degarelix—Urticaria—Betamethasone—ankylosing spondylitis	0.00176	0.00176	CcSEcCtD
Degarelix—Urticaria—Dexamethasone—ankylosing spondylitis	0.00176	0.00176	CcSEcCtD
Degarelix—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.00176	0.00176	CcSEcCtD
Degarelix—Dizziness—Prednisolone—ankylosing spondylitis	0.00176	0.00176	CcSEcCtD
Degarelix—Asthenia—Triamcinolone—ankylosing spondylitis	0.00175	0.00175	CcSEcCtD
Degarelix—Abdominal pain—Betamethasone—ankylosing spondylitis	0.00175	0.00175	CcSEcCtD
Degarelix—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.00175	0.00175	CcSEcCtD
Degarelix—Body temperature increased—Betamethasone—ankylosing spondylitis	0.00175	0.00175	CcSEcCtD
Degarelix—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.00175	0.00175	CcSEcCtD
Degarelix—Asthenia—Methylprednisolone—ankylosing spondylitis	0.00175	0.00175	CcSEcCtD
Degarelix—Insomnia—Prednisone—ankylosing spondylitis	0.00175	0.00175	CcSEcCtD
Degarelix—Pruritus—Triamcinolone—ankylosing spondylitis	0.00173	0.00173	CcSEcCtD
Degarelix—Pruritus—Methylprednisolone—ankylosing spondylitis	0.00172	0.00172	CcSEcCtD
Degarelix—Arthralgia—Methotrexate—ankylosing spondylitis	0.00168	0.00168	CcSEcCtD
Degarelix—Decreased appetite—Prednisone—ankylosing spondylitis	0.00168	0.00168	CcSEcCtD
Degarelix—Rash—Prednisolone—ankylosing spondylitis	0.00167	0.00167	CcSEcCtD
Degarelix—Dermatitis—Prednisolone—ankylosing spondylitis	0.00167	0.00167	CcSEcCtD
Degarelix—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.00167	0.00167	CcSEcCtD
Degarelix—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.00167	0.00167	CcSEcCtD
Degarelix—Fatigue—Prednisone—ankylosing spondylitis	0.00166	0.00166	CcSEcCtD
Degarelix—Headache—Prednisolone—ankylosing spondylitis	0.00166	0.00166	CcSEcCtD
Degarelix—Discomfort—Methotrexate—ankylosing spondylitis	0.00166	0.00166	CcSEcCtD
Degarelix—Constipation—Prednisone—ankylosing spondylitis	0.00165	0.00165	CcSEcCtD
Degarelix—Dizziness—Triamcinolone—ankylosing spondylitis	0.00161	0.00161	CcSEcCtD
Degarelix—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.00161	0.00161	CcSEcCtD
Degarelix—Dizziness—Methylprednisolone—ankylosing spondylitis	0.00161	0.00161	CcSEcCtD
Degarelix—Feeling abnormal—Prednisone—ankylosing spondylitis	0.00159	0.00159	CcSEcCtD
Degarelix—Asthenia—Betamethasone—ankylosing spondylitis	0.00159	0.00159	CcSEcCtD
Degarelix—Asthenia—Dexamethasone—ankylosing spondylitis	0.00159	0.00159	CcSEcCtD
Degarelix—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.00158	0.00158	CcSEcCtD
Degarelix—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.00158	0.00158	CcSEcCtD
Degarelix—Nausea—Prednisolone—ankylosing spondylitis	0.00158	0.00158	CcSEcCtD
Degarelix—Pruritus—Betamethasone—ankylosing spondylitis	0.00157	0.00157	CcSEcCtD
Degarelix—Pruritus—Dexamethasone—ankylosing spondylitis	0.00157	0.00157	CcSEcCtD
Degarelix—Skin disorder—Methotrexate—ankylosing spondylitis	0.00157	0.00157	CcSEcCtD
Degarelix—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.00156	0.00156	CcSEcCtD
Degarelix—Vomiting—Triamcinolone—ankylosing spondylitis	0.00155	0.00155	CcSEcCtD
Degarelix—Vomiting—Methylprednisolone—ankylosing spondylitis	0.00155	0.00155	CcSEcCtD
Degarelix—Rash—Triamcinolone—ankylosing spondylitis	0.00154	0.00154	CcSEcCtD
Degarelix—Dermatitis—Triamcinolone—ankylosing spondylitis	0.00154	0.00154	CcSEcCtD
Degarelix—Rash—Methylprednisolone—ankylosing spondylitis	0.00154	0.00154	CcSEcCtD
Degarelix—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.00153	0.00153	CcSEcCtD
Degarelix—Urticaria—Prednisone—ankylosing spondylitis	0.00153	0.00153	CcSEcCtD
Degarelix—Headache—Triamcinolone—ankylosing spondylitis	0.00153	0.00153	CcSEcCtD
Degarelix—Headache—Methylprednisolone—ankylosing spondylitis	0.00153	0.00153	CcSEcCtD
Degarelix—Abdominal pain—Prednisone—ankylosing spondylitis	0.00153	0.00153	CcSEcCtD
Degarelix—Body temperature increased—Prednisone—ankylosing spondylitis	0.00153	0.00153	CcSEcCtD
Degarelix—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.00152	0.00152	CcSEcCtD
Degarelix—Diarrhoea—Betamethasone—ankylosing spondylitis	0.00152	0.00152	CcSEcCtD
Degarelix—Hypotension—Methotrexate—ankylosing spondylitis	0.00151	0.00151	CcSEcCtD
Degarelix—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.00147	0.00147	CcSEcCtD
Degarelix—Dizziness—Betamethasone—ankylosing spondylitis	0.00147	0.00147	CcSEcCtD
Degarelix—Dizziness—Dexamethasone—ankylosing spondylitis	0.00147	0.00147	CcSEcCtD
Degarelix—Insomnia—Methotrexate—ankylosing spondylitis	0.00146	0.00146	CcSEcCtD
Degarelix—Nausea—Triamcinolone—ankylosing spondylitis	0.00145	0.00145	CcSEcCtD
Degarelix—Nausea—Methylprednisolone—ankylosing spondylitis	0.00145	0.00145	CcSEcCtD
Degarelix—Dyspnoea—Methotrexate—ankylosing spondylitis	0.00144	0.00144	CcSEcCtD
Degarelix—Hypersensitivity—Prednisone—ankylosing spondylitis	0.00142	0.00142	CcSEcCtD
Degarelix—Vomiting—Betamethasone—ankylosing spondylitis	0.00141	0.00141	CcSEcCtD
Degarelix—Vomiting—Dexamethasone—ankylosing spondylitis	0.00141	0.00141	CcSEcCtD
Degarelix—Decreased appetite—Methotrexate—ankylosing spondylitis	0.0014	0.0014	CcSEcCtD
Degarelix—Rash—Dexamethasone—ankylosing spondylitis	0.0014	0.0014	CcSEcCtD
Degarelix—Rash—Betamethasone—ankylosing spondylitis	0.0014	0.0014	CcSEcCtD
Degarelix—Dermatitis—Betamethasone—ankylosing spondylitis	0.0014	0.0014	CcSEcCtD
Degarelix—Dermatitis—Dexamethasone—ankylosing spondylitis	0.0014	0.0014	CcSEcCtD
Degarelix—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.00139	0.00139	CcSEcCtD
Degarelix—Fatigue—Methotrexate—ankylosing spondylitis	0.00139	0.00139	CcSEcCtD
Degarelix—Headache—Betamethasone—ankylosing spondylitis	0.00139	0.00139	CcSEcCtD
Degarelix—Headache—Dexamethasone—ankylosing spondylitis	0.00139	0.00139	CcSEcCtD
Degarelix—Asthenia—Prednisone—ankylosing spondylitis	0.00138	0.00138	CcSEcCtD
Degarelix—Pain—Methotrexate—ankylosing spondylitis	0.00138	0.00138	CcSEcCtD
Degarelix—Pruritus—Prednisone—ankylosing spondylitis	0.00137	0.00137	CcSEcCtD
Degarelix—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.00133	0.00133	CcSEcCtD
Degarelix—Diarrhoea—Prednisone—ankylosing spondylitis	0.00132	0.00132	CcSEcCtD
Degarelix—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.00132	0.00132	CcSEcCtD
Degarelix—Nausea—Dexamethasone—ankylosing spondylitis	0.00132	0.00132	CcSEcCtD
Degarelix—Nausea—Betamethasone—ankylosing spondylitis	0.00132	0.00132	CcSEcCtD
Degarelix—Urticaria—Methotrexate—ankylosing spondylitis	0.00128	0.00128	CcSEcCtD
Degarelix—Dizziness—Prednisone—ankylosing spondylitis	0.00128	0.00128	CcSEcCtD
Degarelix—Abdominal pain—Methotrexate—ankylosing spondylitis	0.00127	0.00127	CcSEcCtD
Degarelix—Body temperature increased—Methotrexate—ankylosing spondylitis	0.00127	0.00127	CcSEcCtD
Degarelix—Vomiting—Prednisone—ankylosing spondylitis	0.00123	0.00123	CcSEcCtD
Degarelix—Rash—Prednisone—ankylosing spondylitis	0.00122	0.00122	CcSEcCtD
Degarelix—Dermatitis—Prednisone—ankylosing spondylitis	0.00122	0.00122	CcSEcCtD
Degarelix—Headache—Prednisone—ankylosing spondylitis	0.00121	0.00121	CcSEcCtD
Degarelix—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.00119	0.00119	CcSEcCtD
Degarelix—Asthenia—Methotrexate—ankylosing spondylitis	0.00116	0.00116	CcSEcCtD
Degarelix—Nausea—Prednisone—ankylosing spondylitis	0.00115	0.00115	CcSEcCtD
Degarelix—Pruritus—Methotrexate—ankylosing spondylitis	0.00114	0.00114	CcSEcCtD
Degarelix—Diarrhoea—Methotrexate—ankylosing spondylitis	0.0011	0.0011	CcSEcCtD
Degarelix—Dizziness—Methotrexate—ankylosing spondylitis	0.00107	0.00107	CcSEcCtD
Degarelix—Vomiting—Methotrexate—ankylosing spondylitis	0.00103	0.00103	CcSEcCtD
Degarelix—Rash—Methotrexate—ankylosing spondylitis	0.00102	0.00102	CcSEcCtD
Degarelix—Dermatitis—Methotrexate—ankylosing spondylitis	0.00102	0.00102	CcSEcCtD
Degarelix—Headache—Methotrexate—ankylosing spondylitis	0.00101	0.00101	CcSEcCtD
Degarelix—Nausea—Methotrexate—ankylosing spondylitis	0.000958	0.000958	CcSEcCtD
